Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles selon la gravité.
RéversibilitéGestionGravité
#3
Comment les complications affectent-elles la qualité de vie ?
Les complications peuvent réduire la qualité de vie en limitant les capacités fonctionnelles.
Qualité de vieCapacités fonctionnellesComplications
#4
Y a-t-il des risques de complications à long terme ?
Oui, des risques de complications à long terme existent, notamment des cancers et des maladies chroniques.
RisquesComplications à long termeMaladies chroniques
#5
Les complications peuvent-elles être prévenues ?
Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces.
PréventionSuivi médicalInterventions
Facteurs de risque
5
#1
Quels sont les facteurs de risque pour les anomalies de polyadénylation ?
Les facteurs incluent des mutations génétiques, des expositions environnementales et des infections.
Facteurs de risqueMutations génétiquesInfections
#2
L'âge est-il un facteur de risque ?
Oui, l'âge avancé peut augmenter le risque de mutations affectant la polyadénylation.
ÂgeMutationsRisque
#3
Les habitudes de vie influencent-elles la polyadénylation ?
Des habitudes comme le tabagisme et l'alcoolisme peuvent affecter les mécanismes de polyadénylation.
Habitudes de vieTabagismeAlcoolisme
#4
Les maladies chroniques augmentent-elles les risques ?
Oui, certaines maladies chroniques peuvent prédisposer à des anomalies de polyadénylation.
Maladies chroniquesPrédispositionAnomalies
#5
Les facteurs génétiques jouent-ils un rôle ?
Oui, des antécédents familiaux de maladies peuvent augmenter le risque d'anomalies de polyadénylation.
Facteurs génétiquesAntécédents familiauxRisque
{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Signaux de polyadénylation : Questions médicales les plus fréquentes",
"headline": "Signaux de polyadénylation : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Signaux de polyadénylation : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-07-02",
"dateModified": "2025-03-29",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Signaux de polyadénylation"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Composants de gène",
"url": "https://questionsmedicales.fr/mesh/D040461",
"about": {
"@type": "MedicalCondition",
"name": "Composants de gène",
"code": {
"@type": "MedicalCode",
"code": "D040461",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "G05.360.340.024.340.137"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Signaux de polyadénylation",
"alternateName": "RNA 3' Polyadenylation Signals",
"code": {
"@type": "MedicalCode",
"code": "D039104",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Xiaohui Wu",
"url": "https://questionsmedicales.fr/author/Xiaohui%20Wu",
"affiliation": {
"@type": "Organization",
"name": "Department of Automation, Xiamen University, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Guoli Ji",
"url": "https://questionsmedicales.fr/author/Guoli%20Ji",
"affiliation": {
"@type": "Organization",
"name": "Department of Automation, Xiamen University, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Congting Ye",
"url": "https://questionsmedicales.fr/author/Congting%20Ye",
"affiliation": {
"@type": "Organization",
"name": "National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China."
}
},
{
"@type": "Person",
"name": "Bin Tian",
"url": "https://questionsmedicales.fr/author/Bin%20Tian",
"affiliation": {
"@type": "Organization",
"name": "Gene Expression and Regulation Program, The Wistar Institute, Philadelphia, PA 19104, USA."
}
},
{
"@type": "Person",
"name": "Mihaela Zavolan",
"url": "https://questionsmedicales.fr/author/Mihaela%20Zavolan",
"affiliation": {
"@type": "Organization",
"name": "Computational and Systems Biology, Biozentrum, University of Basel, Spitalstrasse 41, 4056 Basel, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "Non-pharmacological and melatonin interventions for pediatric sleep initiation and maintenance problems: A systematic review and network meta-analysis.",
"datePublished": "2023-06-16",
"url": "https://questionsmedicales.fr/article/37406497",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.smrv.2023.101806"
}
},
{
"@type": "ScholarlyArticle",
"name": "The role of arts therapies in mitigating Sleep Initiation and Maintenance Disorders: a systematic review.",
"datePublished": "2024-05-16",
"url": "https://questionsmedicales.fr/article/38818021",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.3389/fpsyt.2024.1386529"
}
},
{
"@type": "ScholarlyArticle",
"name": "Sleep architecture and sleep-disordered breathing in fatal insomnia.",
"datePublished": "2022-09-20",
"url": "https://questionsmedicales.fr/article/36182725",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.sleep.2022.08.027"
}
},
{
"@type": "ScholarlyArticle",
"name": "Profile of sleep disturbances in patients with recurrent depressive disorder or bipolar affective disorder in a tertiary sleep disorders service.",
"datePublished": "2023-05-31",
"url": "https://questionsmedicales.fr/article/37258713",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-023-36083-7"
}
},
{
"@type": "ScholarlyArticle",
"name": "Insomnia and other sleep disorders in adolescence.",
"datePublished": "2024-07-30",
"url": "https://questionsmedicales.fr/article/39084851",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1136/bmjpo-2021-001229"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Phénomènes génétiques",
"item": "https://questionsmedicales.fr/mesh/D055614"
},
{
"@type": "ListItem",
"position": 3,
"name": "Structures génétiques",
"item": "https://questionsmedicales.fr/mesh/D040342"
},
{
"@type": "ListItem",
"position": 4,
"name": "Génome",
"item": "https://questionsmedicales.fr/mesh/D016678"
},
{
"@type": "ListItem",
"position": 5,
"name": "Composants de génome",
"item": "https://questionsmedicales.fr/mesh/D040481"
},
{
"@type": "ListItem",
"position": 6,
"name": "Gènes",
"item": "https://questionsmedicales.fr/mesh/D005796"
},
{
"@type": "ListItem",
"position": 7,
"name": "Composants de gène",
"item": "https://questionsmedicales.fr/mesh/D040461"
},
{
"@type": "ListItem",
"position": 8,
"name": "Signaux de polyadénylation",
"item": "https://questionsmedicales.fr/mesh/D039104"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Signaux de polyadénylation - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Signaux de polyadénylation",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-08",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Signaux de polyadénylation",
"description": "Comment identifier les signaux de polyadénylation ?\nQuels tests sont utilisés pour étudier la polyadénylation ?\nLes signaux de polyadénylation sont-ils visibles sur des gels ?\nPeut-on détecter des anomalies dans la polyadénylation ?\nQuels marqueurs indiquent une polyadénylation efficace ?",
"url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Signaux de polyadénylation",
"description": "Quels symptômes sont liés à des défauts de polyadénylation ?\nLes maladies génétiques sont-elles liées à la polyadénylation ?\nComment la polyadénylation affecte-t-elle le cancer ?\nY a-t-il des symptômes associés à des ARNm instables ?\nLes infections virales affectent-elles la polyadénylation ?",
"url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Signaux de polyadénylation",
"description": "Peut-on prévenir les anomalies de polyadénylation ?\nQuel rôle joue l'alimentation dans la polyadénylation ?\nLes facteurs environnementaux affectent-ils la polyadénylation ?\nComment le stress oxydatif influence-t-il la polyadénylation ?\nLes vaccinations influencent-elles la polyadénylation ?",
"url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Signaux de polyadénylation",
"description": "Existe-t-il des traitements pour les anomalies de polyadénylation ?\nComment les médicaments peuvent-ils influencer la polyadénylation ?\nLes thérapies ciblées peuvent-elles aider ?\nY a-t-il des approches expérimentales en cours ?\nLes suppléments nutritionnels peuvent-ils aider ?",
"url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Signaux de polyadénylation",
"description": "Quelles complications peuvent survenir avec des défauts de polyadénylation ?\nLes complications sont-elles réversibles ?\nComment les complications affectent-elles la qualité de vie ?\nY a-t-il des risques de complications à long terme ?\nLes complications peuvent-elles être prévenues ?",
"url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Signaux de polyadénylation",
"description": "Quels sont les facteurs de risque pour les anomalies de polyadénylation ?\nL'âge est-il un facteur de risque ?\nLes habitudes de vie influencent-elles la polyadénylation ?\nLes maladies chroniques augmentent-elles les risques ?\nLes facteurs génétiques jouent-ils un rôle ?",
"url": "https://questionsmedicales.fr/mesh/D039104?mesh_terms=Sleep+Initiation+and+Maintenance+Disorders#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment identifier les signaux de polyadénylation ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'analyse bioinformatique et les séquençages d'ARN permettent d'identifier ces signaux."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour étudier la polyadénylation ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests RT-PCR et Northern blot sont couramment utilisés pour étudier la polyadénylation."
}
},
{
"@type": "Question",
"name": "Les signaux de polyadénylation sont-ils visibles sur des gels ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les produits de polyadénylation peuvent être visualisés sur des gels d'agarose après électrophorèse."
}
},
{
"@type": "Question",
"name": "Peut-on détecter des anomalies dans la polyadénylation ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des anomalies peuvent être détectées par des variations dans la taille des ARNm sur des gels."
}
},
{
"@type": "Question",
"name": "Quels marqueurs indiquent une polyadénylation efficace ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "La présence d'une queue poly-A et la stabilité de l'ARNm sont des marqueurs d'efficacité."
}
},
{
"@type": "Question",
"name": "Quels symptômes sont liés à des défauts de polyadénylation ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des défauts peuvent entraîner une instabilité de l'ARNm, affectant la synthèse protéique."
}
},
{
"@type": "Question",
"name": "Les maladies génétiques sont-elles liées à la polyadénylation ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies génétiques peuvent résulter de mutations affectant les signaux de polyadénylation."
}
},
{
"@type": "Question",
"name": "Comment la polyadénylation affecte-t-elle le cancer ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des altérations dans la polyadénylation peuvent conduire à une expression aberrante de gènes oncogènes."
}
},
{
"@type": "Question",
"name": "Y a-t-il des symptômes associés à des ARNm instables ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des ARNm instables peuvent entraîner des troubles métaboliques et des anomalies cellulaires."
}
},
{
"@type": "Question",
"name": "Les infections virales affectent-elles la polyadénylation ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines infections virales peuvent perturber les signaux de polyadénylation, affectant l'hôte."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir les anomalies de polyadénylation ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention passe par une bonne santé génétique et des dépistages précoces des maladies."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'alimentation dans la polyadénylation ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Une alimentation équilibrée peut influencer positivement la régulation des gènes liés à la polyadénylation."
}
},
{
"@type": "Question",
"name": "Les facteurs environnementaux affectent-ils la polyadénylation ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des facteurs comme les toxines peuvent perturber les mécanismes de polyadénylation."
}
},
{
"@type": "Question",
"name": "Comment le stress oxydatif influence-t-il la polyadénylation ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le stress oxydatif peut endommager l'ADN et affecter les signaux de polyadénylation."
}
},
{
"@type": "Question",
"name": "Les vaccinations influencent-elles la polyadénylation ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines recherches suggèrent que les vaccinations peuvent moduler l'expression des gènes liés."
}
},
{
"@type": "Question",
"name": "Existe-t-il des traitements pour les anomalies de polyadénylation ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Actuellement, il n'existe pas de traitements spécifiques, mais des thérapies géniques sont explorées."
}
},
{
"@type": "Question",
"name": "Comment les médicaments peuvent-ils influencer la polyadénylation ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certains médicaments peuvent moduler l'expression des gènes impliqués dans la polyadénylation."
}
},
{
"@type": "Question",
"name": "Les thérapies ciblées peuvent-elles aider ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les thérapies ciblées peuvent potentiellement corriger les défauts de polyadénylation."
}
},
{
"@type": "Question",
"name": "Y a-t-il des approches expérimentales en cours ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des recherches sur des inhibiteurs spécifiques de la polyadénylation sont en cours dans des modèles précliniques."
}
},
{
"@type": "Question",
"name": "Les suppléments nutritionnels peuvent-ils aider ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines études suggèrent que des nutriments spécifiques pourraient soutenir la polyadénylation."
}
},
{
"@type": "Question",
"name": "Quelles complications peuvent survenir avec des défauts de polyadénylation ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des complications incluent des troubles métaboliques, des cancers et des maladies neurodégénératives."
}
},
{
"@type": "Question",
"name": "Les complications sont-elles réversibles ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être gérées, mais d'autres peuvent être irréversibles selon la gravité."
}
},
{
"@type": "Question",
"name": "Comment les complications affectent-elles la qualité de vie ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent réduire la qualité de vie en limitant les capacités fonctionnelles."
}
},
{
"@type": "Question",
"name": "Y a-t-il des risques de complications à long terme ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des risques de complications à long terme existent, notamment des cancers et des maladies chroniques."
}
},
{
"@type": "Question",
"name": "Les complications peuvent-elles être prévenues ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines complications peuvent être prévenues par un suivi médical régulier et des interventions précoces."
}
},
{
"@type": "Question",
"name": "Quels sont les facteurs de risque pour les anomalies de polyadénylation ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les facteurs incluent des mutations génétiques, des expositions environnementales et des infections."
}
},
{
"@type": "Question",
"name": "L'âge est-il un facteur de risque ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, l'âge avancé peut augmenter le risque de mutations affectant la polyadénylation."
}
},
{
"@type": "Question",
"name": "Les habitudes de vie influencent-elles la polyadénylation ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des habitudes comme le tabagisme et l'alcoolisme peuvent affecter les mécanismes de polyadénylation."
}
},
{
"@type": "Question",
"name": "Les maladies chroniques augmentent-elles les risques ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, certaines maladies chroniques peuvent prédisposer à des anomalies de polyadénylation."
}
},
{
"@type": "Question",
"name": "Les facteurs génétiques jouent-ils un rôle ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, des antécédents familiaux de maladies peuvent augmenter le risque d'anomalies de polyadénylation."
}
}
]
}
]
}
National Institute for Data Science in Health and Medicine, Xiamen University, Xiamen, China.
Key Laboratory of the Ministry of Education for Coastal and Wetland Ecosystems, College of the Environment and Ecology, Xiamen University, Xiamen, China.
Department of Biochemistry and Biophysics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA; Graduate Group in Genomics and Computational Biology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA 19104, USA.
Division of Computational Biomedicine, Department of Biological Chemistry, School of Medicine, University of California, Irvine, CA, United States. Electronic address: wei.li@uci.edu.
Sleep initiation and maintenance problems are common in the pediatric population and while behavioral interventions are recommended, their efficacy remains to be evaluated in clinical trials. We condu...
Arts therapies offer effective non-pharmacological intervention for Sleep Initiation and Maintenance Disorders (SIMDs), encompassing both passive and active modalities. This review assesses their effe...
Following PRISMA guidelines, a detailed search across PubMed, the Cochrane Library, Web of Science, and CNKI identified 17 relevant RCTs. Utilizing the Joanna Briggs Institute (JBI) quality criteria a...
Analysis shows arts therapies significantly improve sleep quality. Music therapy and meditation yield immediate benefits, while Tai Chi and Qigong require longer commitment for significant outcomes....
The link between SIMDs and mental health issues like anxiety, stress, and depression suggests arts therapies not only enhance sleep quality but also address underlying mental health conditions. The ev...
PROSPERO, ID: CRD42024506393....
Fatal insomnia (FI) is a rare prion disease severely affecting sleep architecture. Breathing during sleep has not been systematically assessed. Our aim was to characterize the sleep architecture, resp...
Eleven consecutive FI patients (ten familial, one sporadic) were examined with video-polysomnography (vPSG) between 2002 and 2017. Wake/sleep stages and respiration were evaluated using a modified sco...
Median age at onset was 48 years and survival after vPSG was 1 year. All patients had different combinations of breathing disturbances including increased respiratory rate variability (RRV; n = 7), st...
FI patients show frequent breathing alterations, associated with respiratory nuclei damage, and, in addition to NREM sleep distortion, have severe impairment of REM sleep, related with raphe nuclei de...
Bidirectional relationship between sleep disturbances and affective disorders is increasingly recognised, but its underlying mechanisms are far from clear, and there is a scarcity of studies that repo...
Sleep is important for our survival. Research suggests that getting 'good' sleep is a problem for a proportion of adolescents. The paper advocates for holistic treatment of sleep disorders incorporati...
Sleep disorders (SDs) are among many co-morbid medical conditions that affect children with autism spectrum disorder (ASD). Raising awareness and improving the standard of care for children diagnosed ...
Using the Childhood Sleep Habit Questionnaire (CSHQ) to gather data on sleep disorders and SPSS version 26.0 for data analysis, a descriptive cross-sectional study was carried out in the five main aut...
The mean age was 6.90 (± 2.6) years with a boys-to-girls ratio of 2.17:1. The prevalence of SDs (at least one sleep condition almost daily) was 95.65%. Sleep onset 71 (77.2%), limit setting 32 (32.6%)...
The frequency of SDs is significant among children diagnosed with ASD from Sudan, and certain SDs are associated with age and sex. Subsequent studies are required to develop national guidelines for th...
Sleep disorders in older adults increase with aging, likely due to increased sleep latency, decreased sleep efficiency, and total sleep time. Common sleep issues include chronic insomnia, circadian rh...
The purpose of this study was to develop and test the reliability and validity of a 13-item self-report Assessment of Sleep Environment (ASE). This study investigates the relationship between subjecti...
This study aimed to analyze the association between sleep quality and cardiovascular disease in patients on maintenance hemodialysis (MHD)....
A total of 601 patients with MHD in the second affiliated hospital of Nanjing Medical University, were prospectively enrolled in this cohort study from January 2019 to December2019. The global Pittsbu...
Of the 601 patients, 595 patients completed the PSQI assessment, with 278 patients having poor sleep quality. Patients in the PSQI > 7 group were older and had a higher proportion of cardiovascular di...
The prevalence of poor sleep quality was 46.7% in patients with MHD. Poor sleep quality was an independent risk factor for MACEs in patients with MHD....
Sleep disruption is common in older adults and is associated with many poor health outcomes. It is vital for providers to understand insomnia and other sleep disorders in this population. This article...